Literature DB >> 10784559

Use of unlabelled and off licence drugs in children. Use of unlicensed drugs may be recommended in guidelines.

F A Riordan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10784559      PMCID: PMC1127597     

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  4 in total

1.  A look at the future of pediatric therapeutics: an investigator's perspective of the new pediatric rule.

Authors:  J D Connor
Journal:  Pediatrics       Date:  1999-09       Impact factor: 7.124

2.  Regulations requiring manufacturers to assess the safety and effectiveness of new drugs and biological products in pediatric patients--FDA. Final rule.

Authors: 
Journal:  Fed Regist       Date:  1998-12-02

3.  Survey of unlicensed and off label drug use in paediatric wards in European countries. European Network for Drug Investigation in Children.

Authors:  S Conroy; I Choonara; P Impicciatore; A Mohn; H Arnell; A Rane; C Knoeppel; H Seyberth; C Pandolfini; M P Raffaelli; F Rocchi; M Bonati; G Jong; M de Hoog; J van den Anker
Journal:  BMJ       Date:  2000-01-08

4.  Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Joint Tuberculosis Committee of the British Thoracic Society.

Authors: 
Journal:  Thorax       Date:  1998-07       Impact factor: 9.139

  4 in total
  5 in total

1.  The awareness among paediatricians of off-label prescribing in children: a survey of Italian hospitals.

Authors:  Federico Marchetti; Jenny Bua; Alessandro Ventura; Luigi D Notarangelo; Salvatore Di Maio; Giuseppina Migliore; Maurizio Bonati
Journal:  Eur J Clin Pharmacol       Date:  2006-11-24       Impact factor: 2.953

Review 2.  Two decades of off-label prescribing in children: a literature review.

Authors:  Shamala Balan; Mohamed Azmi Ahmad Hassali; Vivienne S L Mak
Journal:  World J Pediatr       Date:  2018-09-14       Impact factor: 2.764

Review 3.  A literature review on off-label drug use in children.

Authors:  Chiara Pandolfini; Maurizio Bonati
Journal:  Eur J Pediatr       Date:  2005-05-24       Impact factor: 3.183

4.  Off-label drug use in a Pediatric Intensive Care Unit.

Authors:  S B Bavdekar; Pranjali A Sadawarte; Nithya J Gogtay; Surabhi S Jain; Sandhya Jadhav
Journal:  Indian J Pediatr       Date:  2009-11       Impact factor: 1.967

5.  Off-label prescribing for allergic diseases in children.

Authors:  Diana Silva; Ignacio Ansotegui; Mário Morais-Almeida
Journal:  World Allergy Organ J       Date:  2014-02-14       Impact factor: 4.084

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.